MedTrace Logo

Atropine Versus no Atropine for Neonatal Rapid Sequence Intubation

NCT01595399 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2013-09-24

No results posted yet for this study

Summary

The purpose of this study is to compare heart rate in infants who receive atropine as a part of their medication before intubation to those who do not.

To be able to find out , we need to divided babies into 2 groups;

group 1 : receives atropine + sedation + muscle relaxant group 2 : receives water or saline ( placebo group) + sedation + muscle relaxant

Then we need to compare heart rate during intubation and duration of intubation between the 2 groups.

Conditions

  • Bradycardia
  • Hypoxemia

Interventions

DRUG

atropine

Atropine 0.02 mg/kg IV

DRUG

Placebo

an equivalent volume of normal saline to atropine IV

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Michael R Narvey, MD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01595399 on ClinicalTrials.gov